Trial Profile
A double-blind, randomized, placebo-controlled study of onabotulinum toxin A (BTX) in patients with trigeminal neuralgia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Oct 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Trigeminal neuralgia
- Focus Therapeutic Use
- 01 Oct 2015 New trial record